← All recalls

Recall · CPSC (US)

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

Biohaven Pharmaceuticals Inc., of New Haven, Conn.·Other·

Yes. Biohaven Pharmaceuticals Inc., of New Haven, Conn.'s product was recalled on March 16, 2023 by CPSC (US). Reported hazard: The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children. What to do: Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Data updated September 22, 2026 · Source: official CPSC (US) recall data, checked daily

Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

What was recalled

This recall involves prescription drugs Nurtec ODT 75 mg orally disintegrating tablets sold in cartons containing one blister card of 8 tablets. The tablets are in a non-child resistant blister card packaged in a carton that includes the name of the product, dosage strength, expiration date. The dosage strength and expiration date are printed or stamped on the blister card. The recall includes the following: Product Description NDC Number Expiration Date Nurtec® ODT (rimegepant) 75mg 8-Unit Dose blister pack 72618-3000-2 All dates through 6/2026

The hazard

CPSC (US) flagged this Biohaven Pharmaceuticals Inc., of New Haven, Conn. product for the following risk:

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

What to do

If you own a Biohaven Pharmaceuticals Inc., of New Haven, Conn. product, here is the remedy CPSC (US) lists:

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Original recall notice: CPSC (US) →

Common questions

Is the Biohaven Pharmaceuticals Inc., of New Haven, Conn. product recalled?

Yes. Biohaven Pharmaceuticals Inc., of New Haven, Conn.'s product was recalled on March 16, 2023 by CPSC (US). Reported hazard: The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

What should I do if I have this product?

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Where can I read the official recall notice?

The original notice is published by CPSC (US) — linked directly from this page.

Want to hear about recalls like this without checking?

We monitor CPSC, FDA, and EU Safety Gate daily. Recall info is always free.

One email a week. Unsubscribe anytime.

Other recalls

More other recalls Pouch has tracked. See all →